Anti-myostatin
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam (NCT05156320) | Scholar Rock, Inc. | 2022-04-14 |
Track Anti-myostatin automatically
Every clearance here is in the API, with alerts when new ones post.